Skip to content
Dose Brief
Menu
No. 161 on the board · Grade C

Lemonaid Health review

Telehealth platform offering some of the lowest entry-tier GLP-1 program pricing on the market.

Visit Lemonaid Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $348/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $348/mo (starting dose, plus a separate fee, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Lemonaid Health scored on our six Brief Score factors. See the methodology.

Price Stability34/100
Supply Reliability74/100
Transparency80/100
Access Breadth80/100
Clinical Oversight74/100
Track Record77/100

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The brief

Best for: Readers who want budget-conscious shoppers. Telehealth platform offering some of the lowest entry-tier GLP-1 program pricing on the market.

Ranked #161 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Lemonaid Health — the realistic shortlist if you're weighing it.

Weighing Lemonaid Health against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Lemonaid Health, and every desk that outranks it is listed on the Lemonaid Health alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Lemonaid Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Lemonaid Health's site. Not medical advice; see our disclosure.

← Back to all rankings